Literature DB >> 2349874

Clinical application of transcutaneous bilirubin measurement. Early prediction of hyperbilirubinemia.

Y Yamauchi1, I Yamanouchi.   

Abstract

The purpose of this study was to investigate whether hyperbilirubinemia (greater than or equal to 15 mg/dl) could be predicted by TcB readings at birth or change of TcB readings during the first 24 hours of life. Both the TcB at 24 hours and the ratio of increase of TcB during the first 24 hours per kg birthweight were useful in predicting the development of hyperbilirubinemia (greater than or equal to 15 mg/dl). The test could be used as a noninvasive screening procedure to detect infants at risk for significant hyperbilirubinemia on the first day of life.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2349874     DOI: 10.1111/j.1651-2227.1990.tb11481.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  2 in total

1.  Estimation of bilirubin using BiliChektrade mark, a transcutaneous bilirubin measurement device: Effects of gestational age and use of phototherapy.

Authors:  Ka Jangaard; H Curtis; Rb Goldbloom
Journal:  Paediatr Child Health       Date:  2006-02       Impact factor: 2.253

2.  Early prediction of neonatal hyperbilirubinemia.

Authors:  S Awasthi; H Rehman
Journal:  Indian J Pediatr       Date:  1998 Jan-Feb       Impact factor: 1.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.